Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ensorcell, LLC was a biotechnology company specializing in the development of nanotechnology-based products for molecular imaging and cancer diagnostics. Founded by Dr. Shuming Nie, a pioneer in nanomedicine, the company focused on commercializing luminescent semiconductor nanocrystals, commonly known as quantum dots, for biological applications. These quantum dots were engineered to target specific biomarkers, providing superior brightness and photostability compared to traditional organic dyes. The company's technology aimed to enable high-sensitivity early detection of cancer and real-time surgical guidance. While the company is no longer active, its intellectual property significantly influenced the field of nanoparticle-based diagnostics and imaging.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ensorcell.